Thomas Leemhuis

779 total citations
13 papers, 555 citations indexed

About

Thomas Leemhuis is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Thomas Leemhuis has authored 13 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Thomas Leemhuis's work include Polyomavirus and related diseases (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and DNA Repair Mechanisms (3 papers). Thomas Leemhuis is often cited by papers focused on Polyomavirus and related diseases (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and DNA Repair Mechanisms (3 papers). Thomas Leemhuis collaborates with scholars based in United States and Germany. Thomas Leemhuis's co-authors include Robert S. Negrin, Matthias Edinger, Christian Scheffold, Stella M. Davies, José A. Cancelas, David A. Williams, Richard E. Harris, Arleen D. Auerbach, Lilith Reeves and Franklin O. Smith and has published in prestigious journals such as Blood, Molecular Therapy and British Journal of Haematology.

In The Last Decade

Thomas Leemhuis

11 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Leemhuis United States 10 295 204 195 160 123 13 555
Theresa Kaeuferle Germany 9 393 1.3× 165 0.8× 207 1.1× 126 0.8× 56 0.5× 15 518
Daniel Hollyman United Kingdom 6 321 1.1× 146 0.7× 171 0.9× 161 1.0× 54 0.4× 10 499
Andrea Arruda Canada 10 163 0.6× 255 1.3× 188 1.0× 41 0.3× 159 1.3× 39 566
Arnold Kloos Germany 14 408 1.4× 241 1.2× 220 1.1× 276 1.7× 85 0.7× 27 630
Régine Vivien France 16 256 0.9× 445 2.2× 70 0.4× 79 0.5× 143 1.2× 24 622
Moniek A. de Witte Netherlands 13 615 2.1× 566 2.8× 181 0.9× 313 2.0× 241 2.0× 31 917
Justin C. Boucher United States 12 398 1.3× 254 1.2× 162 0.8× 131 0.8× 56 0.5× 31 571
Dirk M. van der Steen Netherlands 14 440 1.5× 432 2.1× 283 1.5× 145 0.9× 109 0.9× 28 747
Andrew Medvec United States 8 326 1.1× 455 2.2× 134 0.7× 70 0.4× 27 0.2× 8 736
Christophe Ferrand France 9 188 0.6× 210 1.0× 111 0.6× 206 1.3× 107 0.9× 11 442

Countries citing papers authored by Thomas Leemhuis

Since Specialization
Citations

This map shows the geographic impact of Thomas Leemhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Leemhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Leemhuis more than expected).

Fields of papers citing papers by Thomas Leemhuis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Leemhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Leemhuis. The network helps show where Thomas Leemhuis may publish in the future.

Co-authorship network of co-authors of Thomas Leemhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Leemhuis. A scholar is included among the top collaborators of Thomas Leemhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Leemhuis. Thomas Leemhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Rubinstein, Jeremy D., Carolyn Lutzko, Thomas Leemhuis, et al.. (2022). Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood Advances. 6(9). 2897–2907. 17 indexed citations
4.
Rubinstein, Jeremy D., Sonata Jodele, Jamie Wilhelm, et al.. (2021). Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 28(2). 116.e1–116.e7. 17 indexed citations
5.
Nelson, Adam, Jeremy D. Rubinstein, Anthony Sabulski, et al.. (2020). Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients.. PubMed. 4(22). 5745–5754. 51 indexed citations
6.
Khandelwal, Pooja, Vijaya Chaturvedi, Erika Owsley, et al.. (2019). CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Biology of Blood and Marrow Transplantation. 26(1). 1–6. 12 indexed citations
7.
Reems, Jo‐Anna, Zbigniew M. Szczepiorkowski, David H. McKenna, et al.. (2017). Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T‐cell subpopulations. Transfusion. 57(6). 1555–1565. 26 indexed citations
8.
Mehta, Parinda A., Stella M. Davies, Thomas Leemhuis, et al.. (2017). Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study. Blood. 129(16). 2308–2315. 66 indexed citations
9.
Lutzko, Carolyn, et al.. (2015). FEP cryobags have less breakage after freezing and thawing than eva bags. Cytotherapy. 17(6). S29–S29. 1 indexed citations
10.
Kelly, Patrick, Christof von Kalle, Robin Mueller, et al.. (2006). Stem Cell Collection and Gene Transfer in Fanconi Anemia. Molecular Therapy. 15(1). 211–219. 137 indexed citations
11.
Leemhuis, Thomas, et al.. (2005). A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation. 11(3). 181–187. 184 indexed citations
12.
Boyer, Michael W., Thomas G. Gross, Brett Loechelt, et al.. (2003). Low Risk of Graft-Versus-Host Disease With Transplantation of CD34 Selected Peripheral Blood Progenitor Cells From Alternative Donors for Fanconi Anemia. Journal of Pediatric Hematology/Oncology. 25(11). 890–895. 20 indexed citations
13.
Cornetta, Kenneth, et al.. (1994). Retroviral mediated gene transfer in chronic myelogenous leukaemia. British Journal of Haematology. 87(2). 308–316. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa Kaeuferle Breakdown of academic impact, for papers by Daniel Hollyman Breakdown of academic impact, for papers by Andrea Arruda Breakdown of academic impact, for papers by Arnold Kloos Breakdown of academic impact, for papers by Régine Vivien Breakdown of academic impact, for papers by Moniek A. de Witte Breakdown of academic impact, for papers by Justin C. Boucher Breakdown of academic impact, for papers by Dirk M. van der Steen Breakdown of academic impact, for papers by Andrew Medvec Breakdown of academic impact, for papers by Christophe Ferrand
Rankless by CCL
2026